109. Comparison of plasma lipoprotein (a) levels between individuals attending a metabolic ward with and without a history of ischémie stroke

M. Margaglione, E. Grandone, E. Celentano, G. Vecchione, G. Cappucci, M. Grilli, F. P. Mancini, A. Postiglione, S. Panico, G. Di Minno

Research output: Contribution to journalArticle

Abstract

Objectives. To evaluate the ability of lipoprotein(a), Lp(a), to discriminate subjects with a stroke history, as compared to that of plasminogen activator inhibitor-1 (PAI-1) and tissue plasminogen activator (t-PA). Design. Cross-sectional study. Subjects from a metabolic ward. Participants. A total of 210 subjects (108 men, 102 women, mean age 63.8 yrs, range 31-86) provided plasma and DNA samples for the study. One hundred and one of these (51 males, 50 females) had a history of ischémie stroke. The one hundred and nine subjects who did not have a stroke history, were compared with those with such a history, for major risk factors for ischémie events. Results. Mean plasma t-PA and PAI-1 levels significantly (p50 mg/dl were more common among those with a stroke history (8 with vs 1 without, p50 mg/dl) plasma levels of the lipoprotein.

Original languageEnglish
Pages (from-to)33-34
Number of pages2
JournalFibrinolysis
Volume10
Issue numberSUPPL. 1
Publication statusPublished - 1996

Fingerprint

Lipoprotein(a)
Stroke
Plasminogen Activator Inhibitor 1
Tissue Plasminogen Activator
Lipoproteins
Cross-Sectional Studies
History
DNA

ASJC Scopus subject areas

  • Hematology

Cite this

109. Comparison of plasma lipoprotein (a) levels between individuals attending a metabolic ward with and without a history of ischémie stroke. / Margaglione, M.; Grandone, E.; Celentano, E.; Vecchione, G.; Cappucci, G.; Grilli, M.; Mancini, F. P.; Postiglione, A.; Panico, S.; Di Minno, G.

In: Fibrinolysis, Vol. 10, No. SUPPL. 1, 1996, p. 33-34.

Research output: Contribution to journalArticle

Margaglione, M, Grandone, E, Celentano, E, Vecchione, G, Cappucci, G, Grilli, M, Mancini, FP, Postiglione, A, Panico, S & Di Minno, G 1996, '109. Comparison of plasma lipoprotein (a) levels between individuals attending a metabolic ward with and without a history of ischémie stroke', Fibrinolysis, vol. 10, no. SUPPL. 1, pp. 33-34.
Margaglione, M. ; Grandone, E. ; Celentano, E. ; Vecchione, G. ; Cappucci, G. ; Grilli, M. ; Mancini, F. P. ; Postiglione, A. ; Panico, S. ; Di Minno, G. / 109. Comparison of plasma lipoprotein (a) levels between individuals attending a metabolic ward with and without a history of ischémie stroke. In: Fibrinolysis. 1996 ; Vol. 10, No. SUPPL. 1. pp. 33-34.
@article{cd80eec110564626b4f58c37fb84b20b,
title = "109. Comparison of plasma lipoprotein (a) levels between individuals attending a metabolic ward with and without a history of isch{\'e}mie stroke",
abstract = "Objectives. To evaluate the ability of lipoprotein(a), Lp(a), to discriminate subjects with a stroke history, as compared to that of plasminogen activator inhibitor-1 (PAI-1) and tissue plasminogen activator (t-PA). Design. Cross-sectional study. Subjects from a metabolic ward. Participants. A total of 210 subjects (108 men, 102 women, mean age 63.8 yrs, range 31-86) provided plasma and DNA samples for the study. One hundred and one of these (51 males, 50 females) had a history of isch{\'e}mie stroke. The one hundred and nine subjects who did not have a stroke history, were compared with those with such a history, for major risk factors for isch{\'e}mie events. Results. Mean plasma t-PA and PAI-1 levels significantly (p50 mg/dl were more common among those with a stroke history (8 with vs 1 without, p50 mg/dl) plasma levels of the lipoprotein.",
author = "M. Margaglione and E. Grandone and E. Celentano and G. Vecchione and G. Cappucci and M. Grilli and Mancini, {F. P.} and A. Postiglione and S. Panico and {Di Minno}, G.",
year = "1996",
language = "English",
volume = "10",
pages = "33--34",
journal = "Fibrinolysis and Proteolysis",
issn = "1369-0191",
publisher = "Churchill Livingstone",
number = "SUPPL. 1",

}

TY - JOUR

T1 - 109. Comparison of plasma lipoprotein (a) levels between individuals attending a metabolic ward with and without a history of ischémie stroke

AU - Margaglione, M.

AU - Grandone, E.

AU - Celentano, E.

AU - Vecchione, G.

AU - Cappucci, G.

AU - Grilli, M.

AU - Mancini, F. P.

AU - Postiglione, A.

AU - Panico, S.

AU - Di Minno, G.

PY - 1996

Y1 - 1996

N2 - Objectives. To evaluate the ability of lipoprotein(a), Lp(a), to discriminate subjects with a stroke history, as compared to that of plasminogen activator inhibitor-1 (PAI-1) and tissue plasminogen activator (t-PA). Design. Cross-sectional study. Subjects from a metabolic ward. Participants. A total of 210 subjects (108 men, 102 women, mean age 63.8 yrs, range 31-86) provided plasma and DNA samples for the study. One hundred and one of these (51 males, 50 females) had a history of ischémie stroke. The one hundred and nine subjects who did not have a stroke history, were compared with those with such a history, for major risk factors for ischémie events. Results. Mean plasma t-PA and PAI-1 levels significantly (p50 mg/dl were more common among those with a stroke history (8 with vs 1 without, p50 mg/dl) plasma levels of the lipoprotein.

AB - Objectives. To evaluate the ability of lipoprotein(a), Lp(a), to discriminate subjects with a stroke history, as compared to that of plasminogen activator inhibitor-1 (PAI-1) and tissue plasminogen activator (t-PA). Design. Cross-sectional study. Subjects from a metabolic ward. Participants. A total of 210 subjects (108 men, 102 women, mean age 63.8 yrs, range 31-86) provided plasma and DNA samples for the study. One hundred and one of these (51 males, 50 females) had a history of ischémie stroke. The one hundred and nine subjects who did not have a stroke history, were compared with those with such a history, for major risk factors for ischémie events. Results. Mean plasma t-PA and PAI-1 levels significantly (p50 mg/dl were more common among those with a stroke history (8 with vs 1 without, p50 mg/dl) plasma levels of the lipoprotein.

UR - http://www.scopus.com/inward/record.url?scp=33846704767&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846704767&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33846704767

VL - 10

SP - 33

EP - 34

JO - Fibrinolysis and Proteolysis

JF - Fibrinolysis and Proteolysis

SN - 1369-0191

IS - SUPPL. 1

ER -